B2
B2 promotes inclusion formation in cellular models of Huntington’s disease and Parkinson’s disease
| Catalog Number | T22595 |
| Alternative Name(s) | Linazolamide intermediate B impurity 2 , CPNQ , 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline |
| Research Area | DNA Damage/DNA Repair|||Chromatin/Epigenetic|||Others |
| Molecular Formula | C20H17ClN4O3 |
| CAS# | 115687-05-3 |
| SMILES | [O-][N+](=O)C1=C2N=CC=CC2=C(C=C1)N1CCN(CC1)C(=O)C1=CC=C(Cl)C=C1 |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/B2 |
| Additional Information | https://www.targetmol.com/datasheet/T22595 |